摘要
本期全球医药行业预测报告,汇集了EvaluatePharma从多方面对行业的分析,从世界金融市场出发,全面展望2015至2020年间行业的预期表现。基于对世界5 000强制药和生物技术公司的追踪分析,重点探讨处方药销售、专利风险、研发支出、全球品牌药物销售以及各治疗领域市场表现的趋势,同时简要回顾2014年行业表现。
The eighth edition of EvaluatePhamla＇s World Preview brings together many of our analyses to provide a top level insight, from the world＇s financial markets, into the expected performance of the industry between now and 2020. Based on EvaluatePharma＇s coverage of the world＇s leading 5,000 pharmaceutical and biotech companies, the World Preview highlights trends in prescription drug sales, patent risk, R＆D spend, global brand sales and market performance by therapy area. Also included in the report is a brief review of 2014 performance.
出处
《药学进展》
CAS
2015年第9期690-700,共11页
Progress in Pharmaceutical Sciences
关键词
处方药
非处方药
销售市场
研发支出
并购
风投
利润
prescription drug
OTC
sales market
R＆D spend
M＆A
venture financing
income
